| 臺大學術典藏 |
2020-05-25T01:32:57Z |
Diagnosis of mediastinal tuberculous lymphadenitis using endobronchial ultrasound-guided transbronchial needle aspiration with rinse fluid polymerase chain reaction
|
Lin C.-K.; Keng L.-T.; Lim C.-K.; YEN-TING LIN; Lin S.-Y.; Chen L.-Y.; Yao Z.-H.; Chen Y.-H.; Ho C.-C. |
| 臺大學術典藏 |
2020-05-25T01:32:56Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
Shih J.-Y.;Yu C.-J.;Liu Y.-N.;Wu S.-G.;Tsai T.-H.;YEN-TING LIN; YEN-TING LIN; Tsai T.-H.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-20T05:33:08Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
JIN-YUAN SHIH;YEN-TING LIN;Tsai, Meng-Feng;Chang, Tzu-Hua;HSU, CHIA-LANG;Wu, Shang-Gin;Liu, Yi-Nan;Wang, Hsin-Yi; Wang, Hsin-Yi; Liu, Yi-Nan; Wu, Shang-Gin; HSU, CHIA-LANG; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-05-20T05:27:09Z |
Real-World Crizotinib Use for Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer under First-Year National Health Insurance Coverage in Taiwan
|
JIN-YUAN SHIH;CHUNG-YU CHEN;YEN-TING LIN; YEN-TING LIN; CHUNG-YU CHEN; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-05-20T05:11:45Z |
Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer
|
Wu S.-G.; Shih J.-Y.; Yang P.-C.; Yu C.-J.; Yang J.C.-H.; Wang Y.-F.; YEN-TING LIN; Yang P.-C.;Shih J.-Y.;Wu S.-G.;Yu C.-J.;Yang J.C.-H.;Wang Y.-F.;YEN-TING LIN |
| 臺大學術典藏 |
2020-05-20T05:11:44Z |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non�VSmall-Cell Lung Cancer: Analysis and Literature Review
|
Yang J.C.-H.; Yu C.-J.; YEN-TING LIN; Shih J.-Y.;Yang J.C.-H.;Yu C.-J.;YEN-TING LIN; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-20T05:11:44Z |
Plasma zinc alpha2-glycoprotein levels correlate positively with frailty severity in female elders
|
Tsai J.-S.;Lee C.-S.;YEN-TING LIN;Chang C.-I.;Hsu C.-C.;Chen C.-Y.;Chen C.-Y.;Liu H.-H.;Chang C.-H.;Lee Y.-P.; Lee Y.-P.; Chang C.-H.; Liu H.-H.; Chen C.-Y.; Chen C.-Y.; Hsu C.-C.; Chang C.-I.; YEN-TING LIN; Lee C.-S.; Tsai J.-S. |
| 臺大學術典藏 |
2020-05-20T05:11:44Z |
The association between glomerular hyperfiltration and left ventricular structure and function in patients with primary aldosteronism
|
Wu K.-D.; Ho Y.-L.; Wu V.-C.; TAIPAI Study Group;Lin Y.-H.;Wu K.-D.;Ho Y.-L.;Wu V.-C.;Lin L.-Y.;Lai C.-L.;Lin L.-C.;Hung C.-S.;Chang Y.-Y.;YEN-TING LIN;Lu C.-C.;Chen Y.-H.;Liao C.-W.;Chang C.-C.;Wu X.-M.;Liao M.-T.; Liao M.-T.; Wu X.-M.; Chang C.-C.; Liao C.-W.; Chen Y.-H.; Lu C.-C.; YEN-TING LIN; Chang Y.-Y.; Hung C.-S.; Lin L.-C.; Lai C.-L.; Lin L.-Y.; Lin Y.-H.; TAIPAI Study Group |
| 臺大學術典藏 |
2020-05-20T05:11:43Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non�VSmall-cell Lung Cancer
|
Shih J.-Y.;Yang J.C.-H.;Wu S.-G.;Liu Y.-N.;YEN-TING LIN; YEN-TING LIN; Liu Y.-N.; Wu S.-G.; Yang J.C.-H.; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-20T05:11:43Z |
Transthoracic Ultrasound Elastography in Pulmonary Lesions and Diseases
|
Yu C.-J.;Wang H.-C.;Lai Y.-C.;Chang C.-H.;YEN-TING LIN;Chung C.-L.;Lim C.-K.; Lim C.-K.; Chung C.-L.; YEN-TING LIN; Chang C.-H.; Lai Y.-C.; Wang H.-C.; Yu C.-J. |
| 臺大學術典藏 |
2020-05-20T05:11:43Z |
Effects of 12 weeks of atorvastatin therapy on myocardial fibrosis and circulating fibrosis biomarkers in statin-na?ve patients with hypertension with atherosclerosis
|
Lin Y.-H.;Lin H.-J.;Hung C.-S.;Kao H.-L.;YEN-TING LIN;Lin Y.-M.;Lee J.-K.;Wu Y.-W.;Chang Y.-Y.; Chang Y.-Y.; Wu Y.-W.; Lee J.-K.; Lin Y.-M.; YEN-TING LIN; Kao H.-L.; Hung C.-S.; Lin H.-J.; Lin Y.-H. |
| 臺大學術典藏 |
2020-05-20T05:11:42Z |
Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas
|
Shih J.-Y.;Liu Y.-N.;YEN-TING LIN;Hsieh M.-S.;Gow C.-H.; Gow C.-H.; Hsieh M.-S.; YEN-TING LIN; Liu Y.-N.; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-20T05:11:42Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yu C.-J.;Yang J.C.-H.;Shih J.-Y.;Lin Z.-Z.;Lee J.-H.;Chen K.-Y.;Yang C.-Y.;Hsu C.-L.;Ho C.-C.;Liao W.-Y.;Chen J.-S.;YEN-TING LIN; YEN-TING LIN; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-05-20T05:11:42Z |
The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4�VALK Rearranged Non-small Cell Lung Cancer
|
Shih J.-Y.;Liu Y.-N.;YEN-TING LIN; YEN-TING LIN; Liu Y.-N.; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-20T05:11:41Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
Shih J.-Y.; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Tsai T.-H.; YEN-TING LIN; Shih J.-Y.;Yu C.-J.;Liu Y.-N.;Wu S.-G.;Tsai T.-H.;YEN-TING LIN |
| 臺大學術典藏 |
2020-05-20T05:11:41Z |
Diagnosis of mediastinal tuberculous lymphadenitis using endobronchial ultrasound-guided transbronchial needle aspiration with rinse fluid polymerase chain reaction
|
Ho C.-C.;Chen Y.-H.;Yao Z.-H.;Chen L.-Y.;Lin S.-Y.;YEN-TING LIN;Lim C.-K.;Keng L.-T.;Lin C.-K.; Lin C.-K.; Keng L.-T.; Lim C.-K.; YEN-TING LIN; Lin S.-Y.; Chen L.-Y.; Yao Z.-H.; Chen Y.-H.; Ho C.-C. |
| 臺大學術典藏 |
2020-04-28 |
An international real-world analysis of efficacy and safety of lorlatinib via early or expanded access programs in patients with TKI-refractory ALK+ or ROS1+ NSCLC
|
Soo, Ross A; Chia-Chi Lin; Soo, Ross A;Chia-Chi Lin;Reungwetwattana, Thanyanan;Syn, Nicholas L;Ignatius Ou, Sai-Hong;Tchekmedyian, Nishan;Ock, Chan-Young;Ang, Yvonne L E;To, Hao;Nagasaka, Misako;Loong, Herbert H;Kim, Dong-Wan;YEN-TING LIN;Zhu, Viola W; Zhu, Viola W; YEN-TING LIN; Kim, Dong-Wan; Loong, Herbert H; Nagasaka, Misako; To, Hao; Ang, Yvonne L E; Ock, Chan-Young; Tchekmedyian, Nishan; Ignatius Ou, Sai-Hong; Syn, Nicholas L; Reungwetwattana, Thanyanan |
| 嘉南藥理大學 |
2020 |
A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice
|
Sheu, Joen-Rong; Chen, Zhih-Cherng; Jayakumar, Thanasekaran; Chou, Duen-Suey; Yen, Ting-Lin; Lee, Hsing-Ni; Pan, Szu-Han; Hsia, Chih-Hsuan; Yang, Chih-Hao; Hsieh, Cheng-Ying |
| 嘉南藥理大學 |
2020 |
A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice
|
Sheu, Joen-Rong; Chen, Zhih-Cherng; Jayakumar, Thanasekaran; Chou, Duen-Suey; Yen, Ting-Lin; Lee, Hsing-Ni; Pan, Szu-Han; Hsia, Chih-Hsuan; Yang, Chih-Hao; Hsieh, Cheng-Ying |
| 臺大學術典藏 |
2019-12-23T03:27:22Z |
Diagnosis of mediastinal tuberculous lymphadenitis using endobronchial ultrasound-guided transbronchial needle aspiration with rinse fluid polymerase chain reaction
|
Ching-Kai Lin; Chor-Kuan Lim; Yen-Ting Lin; Shu-Yung Lin; Li-Yang Chen; Zong-Han Yao; Yung-Hsuan Chen; Chao-Chi Ho;LI-TA KENG; LI-TA KENG; Ching-Kai Lin; Chor-Kuan Lim; Yen-Ting Lin; Shu-Yung Lin; Li-Yang Chen; Zong-Han Yao; Yung-Hsuan Chen; Chao-Chi Ho |
| 臺大學術典藏 |
2019-10-24T07:28:01Z |
A 40-GHz high linearity transmitter in 65-nm CMOS technology with 32-dBm OIP3
|
王暉;HUEI WANG;Huei Wang;Chun-Nien Chen;Yen-Ting Lin;Tai-Yu Kuo; Tai-Yu Kuo; Yen-Ting Lin; Chun-Nien Chen; Huei Wang; HUEI WANG; 王暉 |
| 臺大學術典藏 |
2019-10-24T07:28:01Z |
A 40-GHz high linearity transmitter in 65-nm CMOS technology with 32-dBm OIP3
|
王暉;HUEI WANG;Huei Wang;Chun-Nien Chen;Yen-Ting Lin;Tai-Yu Kuo; Tai-Yu Kuo; Yen-Ting Lin; Chun-Nien Chen; Huei Wang; HUEI WANG; 王暉 |
| 淡江大學 |
2019-09-25 |
Improvement of mechanical properties and anticorrosion performance of epoxy coatings by the introduction of polyaniline/graphene composite
|
Yen-Ting Lin; Trong-Ming Don; Chong-Jun Wong; Fan-Chun Meng; Yi-Jun Lin; Shaio-Yen Lee; Chia-Fen Lee; Wen-Yen Chiu |
| 臺大學術典藏 |
2019-02-27T07:04:21Z |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review
|
James Chih-Hsin Yang;Yen-Ting Lin;JIN-YUAN SHIH;CHONG-JEN YU; Yen-Ting Lin; Chong-Jen Yu; James Chih-Hsin Yang; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019 |
The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer
|
YEN-TING LIN; Liu Y.-N.; Shih J.-Y. |
